doi: 10.2147/IMCRJ.S74563 [PubMed] 25873702 Janssen J, Singh-Saluja S
Schilling Test The flushing dose is 1,000 mcg
The typical escalation moves from 0.25 mg to 0.5 mg at week 5, then to 1 mg at week 9, followed by 1.7 mg at week 13, and finally reaching the full maintenance dose of 2.4 mg semaglutide with 2.4 mg cagrilintide at week 17
Multipotent stromal cells called mesenchymal stem cells (MSCs) have the ability to differentiate into a variety of cell types, such as adipocytes, osteoblasts, and chondrocytes
Future research needs to focus on finding biomarkers, such as ARG1/iNOS expression or TAM polarization status, to predict which patients are most likely to benefit